Nordic Life Science | Pharma
229 FOLLOWERS
The leading Nordic life is a science magazine and news site, provides you with the latest business, pharma, biotech, and MedTech news. With high editorial credibility and a hand-picked team of experts, editors, and journalists serve a reading experience of the highest quality and a greater comprehension and explanation of the Nordic life science industry.
Nordic Life Science | Pharma
1d ago
Researchers at Chalmers University of Technology in Sweden have carried out one of the largest studies to date using AI (artificial intelligence)-assisted image analysis of lymphoma. “An AI-based computer system ..read more
Nordic Life Science | Pharma
1d ago
Voydeya has been approved as an add-on to ravulizumab or eculizumab for the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who have residual haemolytic anaemia. Voydeya is a ..read more
Nordic Life Science | Pharma
1d ago
The company has announced the successful closure of an oversubscribed bridge financing round. Funding was provided by existing investors, such as Northern Venture CapSek, and new shareholders. The money will ..read more
Nordic Life Science | Pharma
1d ago
Moving its lab and U.S. headquarters to Research Triangle Park supports the strategy Immunovia announced in July 2023 to streamline operations and reduce costs. The move to Research Triangle Park ..read more
Nordic Life Science | Pharma
1d ago
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of ..read more
Nordic Life Science | Pharma
1d ago
Medivir’s selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease Designation (RPDD) as well as Orphan Drug Designation (ODD) for the treatment of Legg-Calvé-Perthes Disease (LCPD). The FDA ..read more
Nordic Life Science | Pharma
1d ago
Genmab and Pfizer have announced that the FDA has approved the supplemental Biologics License Application for TIVDAK for the treatment of patients with recurrent or metastatic cervical cancer with disease ..read more
Nordic Life Science | Pharma
1w ago
Curida Holding has announced a significant growth investment from Signet Healthcare Partners, a New York-based healthcare private equity firm together with existing shareholders, Canica, Investinor, Klaveness Marine and Farvatn Private ..read more
Nordic Life Science | Pharma
3w ago
Elypta has announced that the interim results from the LEVANTIS-0087A study will be presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting in San Diego during the ..read more
Nordic Life Science | Pharma
3w ago
The US-based private equity firm has committed to acquire Recipharm’s sites in Solna, Strängnäs, Höganäs, Karlskoga and Uppsala OTC Development in Sweden, Pessac in France, and Parets in Spain. The ..read more